jbog is it just me or have you been a little bullish on MNTA as of late?! :)
I'm very positive on Momenta as a trade going through the copaxone approvals.
I've said it many times that you can make money on Momenta but it'll only be event driven. I expect a nice pop when the approval happens and then it'll go back to be the same hum drum stock that we have witnessed.
Management has not been forced to excel so they won't. I can't think of any other biotech who spends so much and delivers so little. Momenta is in a class by itself and it would be a great acquisition for someone like Royalty Pharma and they could siphon the proceeds off and shutdown everything else.
Market Data 
Markets 
AI
